Belite Bio, Inc. (BLTE)
169.85
+2.60
(+1.55%)
USD |
NASDAQ |
Apr 02, 16:00
169.50
-0.35
(-0.21%)
After-Hours: 20:00
Belite Bio EPS Diluted (Quarterly) : -0.6992 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocugen, Inc. | -0.0567 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.32M |
| Total Expenses (Quarterly) | 25.32M |
| Enterprise Value | 6.190B |
| Earnings Yield | -1.33% |
| Normalized Earnings Yield | -1.335 |